Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Cross Country Healthcare Inc
NASDAQ:CCRN

Watchlist Manager
Cross Country Healthcare Inc Logo
Cross Country Healthcare Inc
NASDAQ:CCRN
Watchlist
Price: 8.225 USD -2.08% Market Closed
Market Cap: $269.5m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

Assets
+
3Y
-39%
5Y
+50%
10Y
+58%
Liabilities
+
3Y
-72%
5Y
-38%
10Y
-34%
Equity
+
3Y
-3%
5Y
+175%
10Y
+188%

Balance Sheet Decomposition
Cross Country Healthcare Inc

Balance Sheet
Cross Country Healthcare Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
3
17
0
0
0
0
9
10
7
11
11
11
8
5
3
21
26
16
1
2
1
4
17
82
Cash Equivalents
3
17
0
0
0
0
9
10
7
11
11
11
8
5
3
21
26
16
1
2
1
4
17
82
Short-Term Investments
0
0
0
0
0
0
0
0
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
89
100
115
99
120
118
117
119
78
71
78
69
69
119
150
177
177
170
175
175
499
660
388
243
Accounts Receivables
87
98
112
95
108
115
116
118
70
64
72
63
61
113
147
174
174
166
170
170
494
642
372
223
Other Receivables
2
2
2
3
12
3
1
1
8
7
7
6
8
6
3
3
4
4
5
5
5
18
16
20
Other Current Assets
17
12
13
18
23
25
23
32
19
19
19
60
7
7
7
8
6
9
8
7
8
12
10
10
Total Current Assets
109
128
127
117
143
142
149
161
106
103
110
139
84
131
159
206
209
195
183
183
508
676
415
335
PP&E Net
9
12
13
12
17
21
24
26
20
15
12
8
6
12
11
13
14
14
29
23
23
23
30
31
PP&E Gross
9
12
13
12
17
21
24
26
20
15
12
8
6
12
11
13
14
14
29
23
23
23
30
31
Accumulated Depreciation
9
13
17
11
15
20
26
33
42
43
42
42
45
48
39
43
31
34
23
17
18
18
16
19
Intangible Assets
25
23
24
22
21
27
35
97
91
77
73
63
69
72
83
72
88
76
51
41
48
45
54
42
Goodwill
219
226
308
303
303
310
326
123
131
143
143
63
77
91
95
80
118
101
101
91
120
163
135
135
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
8
11
17
17
16
17
16
14
13
14
23
26
21
Other Long-Term Assets
1
1
3
2
1
1
1
19
9
6
10
25
2
2
1
2
22
26
4
6
19
18
19
25
Other Assets
219
226
308
303
303
310
326
123
131
143
143
63
77
91
95
80
118
101
101
91
120
163
135
135
Total Assets
362
N/A
391
+8%
475
+21%
456
-4%
484
+6%
501
+4%
535
+7%
426
-20%
357
-16%
344
-4%
348
+1%
306
-12%
248
-19%
325
+31%
366
+12%
388
+6%
468
+20%
427
-9%
382
-10%
357
-7%
733
+105%
948
+29%
679
-28%
589
-13%
Liabilities
Accounts Payable
3
3
10
6
12
14
10
12
8
8
9
10
10
27
41
59
51
44
46
50
110
159
155
44
Accrued Liabilities
27
30
30
32
48
36
26
21
16
15
21
23
22
31
27
31
32
31
34
38
67
100
65
65
Short-Term Debt
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
14
5
2
6
2
5
16
6
8
17
34
9
4
8
2
7
5
0
0
4
0
0
0
Other Current Liabilities
2
3
3
4
4
6
9
4
5
5
4
6
5
5
10
5
6
6
6
6
19
13
15
12
Total Current Liabilities
36
50
48
45
70
57
50
53
35
35
51
73
45
67
86
97
95
85
86
93
200
272
149
120
Long-Term Debt
45
29
89
40
20
20
34
117
57
46
25
0
0
71
81
85
92
78
71
53
176
149
0
0
Deferred Income Tax
9
11
18
25
35
40
49
0
0
0
0
0
17
18
19
13
0
0
8
7
0
0
0
1
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
0
0
0
Other Liabilities
3
1
0
0
0
9
11
21
19
17
22
24
26
39
38
42
43
45
55
49
59
70
57
49
Total Liabilities
92
N/A
90
-2%
154
+71%
110
-29%
124
+13%
126
+1%
145
+15%
192
+33%
111
-42%
98
-12%
99
+1%
97
-2%
88
-10%
195
+123%
225
+15%
237
+6%
231
-3%
210
-9%
220
+5%
203
-8%
435
+115%
491
+13%
206
-58%
170
-17%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
13
43
69
89
104
121
144
2
8
5
10
33
85
117
112
104
67
84
142
155
23
166
238
218
Additional Paid In Capital
258
259
252
257
255
254
246
237
241
243
243
245
246
248
254
257
305
303
306
310
322
293
236
202
Other Equity
1
0
0
0
0
0
0
5
3
2
3
3
1
1
1
1
1
2
1
1
1
1
1
1
Total Equity
270
N/A
301
+11%
321
+7%
346
+8%
359
+4%
375
+4%
390
+4%
234
-40%
246
+5%
246
0%
249
+1%
209
-16%
161
-23%
130
-19%
141
+8%
151
+7%
237
+57%
218
-8%
163
-25%
154
-5%
298
+93%
457
+54%
473
+4%
419
-11%
Total Liabilities & Equity
362
N/A
391
+8%
475
+21%
456
-4%
484
+6%
501
+4%
535
+7%
426
-20%
357
-16%
344
-4%
348
+1%
306
-12%
248
-19%
325
+31%
366
+12%
388
+6%
468
+20%
427
-9%
382
-10%
357
-7%
733
+105%
948
+29%
679
-28%
589
-13%
Shares Outstanding
Common Shares Outstanding
32
32
32
32
32
32
32
31
31
31
31
31
31
31
32
32
36
36
36
36
37
36
34
32

See Also

Summary
CCRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCRN stock valuation using valuation multiples.
Wall Street Estimates
CCRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.